Published in:
01-08-2005
Feature Section, Radiofrequency Tumor Ablation, Under The Guest Editorship of A. R. Gillams
Author:
Morton A. Meyers
Published in:
Abdominal Radiology
|
Issue 4/2005
Login to get access
Excerpt
Radiofrequency ablation (RFA) of tumors is a therapeutic modality that has been rapidly accepted in academic centers and community hospitals. Although it is currently used for primary and metastatic tumors of the kidney, bones, lungs, breast, and head and neck, it is most commonly used for therapy of unresectable tumors in the liver. Italian researchers have recently suggested that RFA should be offered as first-line therapy for patients with liver tumors. In patients who had cirrhosis and hepatocellular carcinoma controlled only with RFA, 5-year survival rates appeared to be similar, and in some cases superior, to those for surgery. …